Nuo Therapeutics, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.

Symbol
AURX on OTC
Location
Houston, TX
Fiscal year end
31 December
Latest financial report
30 Mar 2026

Latest SEC snapshot (2026-03-26) highlights Return On Equity 1134.6%, Return On Assets -165.5%, and Current Ratio 1.06x.

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

64.8/100

Balanced Confidence medium

Return On Equity

1135%

Metric score 100.0/100

Return On Assets

-166%

Metric score 0.0/100

Financial Health

Current Ratio
1.06x
Quick Ratio
0.85x

Strengths

Return On Equity, Current Ratio, and Quick Ratio

Watchpoints

Return On Assets and NetIncomeLoss YoY

Key metrics snapshot

Return On Equity

1135%

YoY: -479%

Industry median: -18% (n=176)

View history

Return On Assets

-166%

YoY: +9.3%

Industry median: -36% (n=175)

View history

Current Ratio

1.06x

YoY: -27%

Industry median: 2.36x (n=176)

View history

Quick Ratio

0.85x

YoY: -7.5%

Industry median: 1.88x (n=146)

View history

NetIncomeLoss YoY

-8.1%

YoY:

Industry median: 0.49% (n=168)

View history

Profitability

Metric Latest value YoY change
Return On Equity 1135% -479%
Return On Assets -166% +9.3%

Financial Health

Metric Latest value YoY change
Current Ratio 1.06x -27%
Quick Ratio 0.85x -7.5%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -8.1%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 48,289,296 +3.1%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%